Document is current
Any future updates will be listed below
-
Authors
,
Ashley, Elizabeth A.
Baron, Emmanuel
Bouyou-Akotet, Marielle K.
Burrow, Rebekah
Carn, Gwenaelle
Carrara, Verena I.
Comets, Emmanuelle
Csajka, Chantal
D’Alessandro, Umberto
Day, Nicholas P.
Djimde, Abdoulaye A.
Dondorp, Arjen
Duparc, Stephan
Faiz, MAbul
Ferreira, Marcelo Urbano
Fleckenstein, Lawrence
Gaye, Oumar
Genton, Blaise
Guerin, Philippe J.
Hodel, Eva Maria
Humphreys, Georgina S.
Kremsner, Peter G.
Krudsood, Srivicha
Ladeia-Andrade, Simone
Lefèvre, Gilbert
Mansoor, Rashid
Mayxay, Mayfong
Newton, Paul N.
Nosten, Francois
Phyo, Aung Pyae
Price, Ric N.
Pukrittayakamee, Sasithon
Ramharter, Michael
Rueangweerayut, Ronnatrai
Sagara, Issaka
Sirima, Sodiomon B.
Smithuis, Frank M.
Stepniewska, Kasia
Taylor, Walter R. J.
Valéa, Innocent
Valecha, Neena
van den Broek, Ingrid V. F.
van der Pluijm, Rob W.
van Vugt, Michèle
Ward, Stephen A.
White, Nicholas J.
- License Information
-
More Information
Article History
Received: 15 March 2026
Accepted: 26 May 2026
First Online: 25 August 2026
Declarations
Ethics approval and consent to participate: All data included in this analysis were obtained in accordance with the laws and ethical approvals applicable to the countries in which the studies were conducted, and were obtained with the knowledge and consent of the individual to whom they relate. Pseudonymised data which could not be traced back to individuals were shared with WWARN. This analysis does not require review of the Ethics Committee under the guidelines of the Oxford Central University Research Ethics Committee.
Consent for publication: Not applicable.
Competing interests: GC works for DNDi who developed the first coformulation of AS-MQ. WRJT was employed by WHO-TDR previously, and was the study monitor for a trial of the AS-MQ FDC. Various authors worked on studies used to register the new FDC. EAA was Associate Editor at Malaria Journal from 2015–2025.
